SIREN : 840069512
UNIVERSEL BIO is a French company founded 7 years ago, specialized in the sector Commerce de détail d'habillement en magasin spécialisé. Based in ANNEMASSE (74100), this company of category PME shows in 2020 a revenue of 23 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 | 2019 | 2018 |
|---|---|---|---|
| Revenue | 22 512 € | 5 398 € | N/C |
| Net income | 17 273 € | -9 650 € | -3 563 € |
| EBITDA | 17 849 € | -8 586 € | -3 740 € |
| Net margin | 76.7% | -178.8% | N/C |
In 2020, UNIVERSEL BIO achieves revenue of 23 k€. Over the period 2019-2020, the company shows strong growth with a CAGR (compound annual growth rate) of +317.0%. Vs 2019, growth of +317% (5 k€ -> 23 k€). After deducting consumption (13 k€), gross margin stands at 9 k€, i.e. a rate of 41%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 18 k€, representing 79.3% of revenue. Positive scissor effect: EBITDA margin improves by +238.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 17 k€, i.e. 76.7% of revenue. This profit can be retained or distributed to shareholders.
22 512 €
9 339 €
17 849 €
17 426 €
17 273 €
39.1%
The debt ratio (= Financial debt / Equity x 100) stands at 230%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 78.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
230.342%
46.968%
78.611%
0.0
76.4%
In 2020, the debt ratio of UNIVERSEL BIO (230.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2020, the financial autonomy of UNIVERSEL BIO (47.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2020, the repayment capacity of UNIVERSEL BIO (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 111.80. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.9x. Danger: operating income does not cover interest charges, unsustainable situation.
111.803
0.885
In 2020, the liquidity ratio of UNIVERSEL BIO (111.80) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2020, the interest coverage of UNIVERSEL BIO (0.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 75 days. Excellent situation: suppliers finance 75 days of the operating cycle (retail model). Inventory turnover is 472 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. WCR is negative (-57 days): operations structurally generate cash.
-3 586 €
0 j
75 j
472 j
-57 j
Based on 96 transactions of similar company sales
in 2020,
the value of UNIVERSEL BIO is estimated at
33 090 €
(range 12 941€ - 75 190€).
With an EBITDA of 17 849€, the sector multiple of 3.0x is applied.
The price/revenue ratio is 0.20x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 96 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare UNIVERSEL BIO with other companies in the same sector:
Voir toutes les statistiques du secteur Commerce de détail d'habillement en magasin spécialisé
The revenue of UNIVERSEL BIO in 2020 is 23 k€.
Yes, UNIVERSEL BIO generated a net profit of 17 k€ in 2020.
The headquarters of UNIVERSEL BIO is located in ANNEMASSE (74100), in the department Haute-Savoie.
The tax return of UNIVERSEL BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
UNIVERSEL BIO operates in the sector Commerce de détail d'habillement en magasin spécialisé (NAF code 47.71Z). See the 'Sector positioning' section above to compare the company with its competitors.